Orexigen Therapeutics Reports Corporate and Financial Results for the Second Quarter Ended June 30, 2014
Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced corporate and financial results ...